COMMUNIQUÉ DE PRESSE publié le 20/12/2024 à 15:15, il y a 1 année 10 mois Quantum Biopharma Diversifies Treasury With the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency Quantum BioPharma Ltd. purchases $1,000,000 Bitcoin and other cryptocurrencies, allows cryptocurrency transactions, emphasizing compliance and potential returns for shareholders Bitcoin Compliance Investment Cryptocurrency Quantum BioPharma
BRÈVE publiée le 14/12/2024 à 01:05, il y a 1 année 11 mois Quantum BioPharma conclut la première tranche de son offre Première Tranche Biopharmacie Quantique Unités D'obligations Développement Du Capital Dollars Canadiens
BRÈVE publiée le 14/12/2024 à 01:05, il y a 1 année 11 mois Quantum BioPharma Concludes Initial Tranche of Offering First Tranche Capital Development Quantum BioPharma Canadian Dollars Debenture Units
COMMUNIQUÉ DE PRESSE publié le 14/12/2024 à 01:00, il y a 1 année 11 mois Quantum Biopharma Announces Closing of First Tranche Quantum BioPharma closes initial tranche of offering, issuing 500 Debenture Units for $500,000. Proceeds for business development and working capital. Securities subject to statutory hold period Working Capital Statutory Hold Period Quantum BioPharma Debenture Units Tranche Offering
BRÈVE publiée le 10/12/2024 à 13:35, il y a 1 année 11 mois Quantum Biopharma avance dans l'essai clinique Lucid-MS Recherche Biopharmaceutique Biopharmacie Quantique Examen De Sécurité Essai Lucid-MS Progrès Clinique
BRÈVE publiée le 10/12/2024 à 13:35, il y a 1 année 11 mois Quantum Biopharma Moves Forward in Lucid-MS Clinical Trial Biopharmaceutical Research Quantum BioPharma Lucid-MS Trial Clinical Advancement Safety Review
COMMUNIQUÉ DE PRESSE publié le 10/12/2024 à 13:30, il y a 1 année 11 mois Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS) Quantum BioPharma announces approval to proceed with dosing of second cohort in Lucid-21-302 trial. Company focused on innovative treatments for neurodegenerative disorders Drug Development Neurodegenerative Disorders Quantum BioPharma Lucid-21-302 Trial Safety Review Committee
BRÈVE publiée le 05/12/2024 à 13:35, il y a 1 année 11 mois Quantum BioPharma Launches Private Placement for $5 Million Private Placement Convertible Debenture Canadian Market Investment Offering Quantum BioPharma
BRÈVE publiée le 05/12/2024 à 13:35, il y a 1 année 11 mois Quantum BioPharma lance un placement privé de 5 millions de dollars Placement Privé Marché Canadien Obligation Convertible Biopharmacie Quantique Offre D'investissement
COMMUNIQUÉ DE PRESSE publié le 05/12/2024 à 13:30, il y a 1 année 11 mois Quantum Biopharma Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of Up to $5 Million Quantum BioPharma announces a non-brokered private placement offering of convertible debenture units. Proceeds for business development and working capital Private Placement Working Capital Business Development Quantum BioPharma Debenture Units
Publié le 18/11/2026 à 07:45, il y a 7 heures 35 minutes Successful pricing of US$ 10 billion of bonds as part of the financing of the PTC acquisition
Publié le 18/11/2026 à 07:45, il y a 7 heures 35 minutes Succès de l’émission obligataire de 10 milliards dollars américains dans le cadre du financement de l’acquisition de PTC
Publié le 18/11/2026 à 14:30, il y a 50 minutes Boron One Announces Non-Binding Heads of Agreement with Multinational Manufacturing Company
Publié le 18/11/2026 à 13:35, il y a 1 heure 45 minutes ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
Publié le 18/11/2026 à 13:30, il y a 1 heure 50 minutes NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
Publié le 18/11/2026 à 13:20, il y a 2 heures Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
Publié le 18/11/2026 à 13:00, il y a 2 heures 20 minutes Silver Storm to Attend the 121 Mining Investment Conference in London, UK
Publié le 18/11/2026 à 15:05, il y a 14 minutes Introducing Cognizant® Patient Hub Operations: AI-enabled patient access offering designed to shorten the path from prescription to therapy
Publié le 18/11/2026 à 15:04, il y a 15 minutes Form 8.3 - The Vanguard Group, Inc.: Intertek Group PLC